|
Originally published In Press as doi:10.1194/jlr.R200005-JLR200 on October 1, 2002
Journal of Lipid Research, Vol. 44, 11-21, January 2003
Copyright © 2003 by Lipid Research, Inc.
Caveolins and macrophage lipid metabolism
Peter Gargalovic and
Ladislav Dory1
Department of Molecular Biology & Immunology, University of North Texas Health Science Center, Fort Worth, TX 76107
1 To whom correspondence should be addressed. e-mail: ldory{at}hsc.unt.edu
The identification of caveolin-1 more than a decade ago initiated active research into its role in the formation of caveolae, membrane trafficking, signal transduction pathways, and lipid homeostasis. Although caveolins are ubiquitously expressed, the majority of the available information comes from differentiated cells rich in caveolins, such as fibroblasts, adipocytes, and endothelial cells. During the development of atherosclerosis, macrophages play a pivotal role in the formation of the fatty streak lesions. They take up large amounts of lipids and accumulate in the subendothelial space, forming foam cells that fill up the lesion area. Since caveolins have been implicated in the regulation of cellular cholesterol metabolism in several cell types, it is of interest to examine their potential function in macrophages.
In this review, we attempt to summarize current knowledge and views on the role of caveolins in cholesterol metabolism with emphasis on macrophages.
Abbreviations: Fr-RPM, Freund's adjuvant-elicited rat peritoneal macrophages; IC, immunocytochemistry; IE, immunoelectron microscopy; MBM, mouse bone marrow-derived macrophages; Res-MPM, resident mouse peritoneal macrophages; Res-RPM, resident rat peritoneal macrophages; RPA, ribonuclease protection assay; RT-PCR, reverse transcription-polymerase chain reaction; Tg-MPM, thioglycollate-elicited mouse peritoneal macrophages; WB, Western blotting Supplementary key words cholesterol transport lipid rafts membranes

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Tamilselvam and S. Daefler
Francisella Targets Cholesterol-Rich Host Cell Membrane Domains for Entry into Macrophages
J. Immunol.,
June 15, 2008;
180(12):
8262 - 8271.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Rigamonti, G. Chinetti-Gbaguidi, and B. Staels
Regulation of Macrophage Functions by PPAR-{alpha}, PPAR-{gamma}, and LXRs in Mice and Men
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2008;
28(6):
1050 - 1059.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Hu, R. D. Ye, M. C. Dinauer, A. B. Malik, and R. D. Minshall
Neutrophil caveolin-1 expression contributes to mechanism of lung inflammation and injury
Am J Physiol Lung Cell Mol Physiol,
February 1, 2008;
294(2):
L178 - L186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bukrinsky and D. Sviridov
Human immunodeficiency virus infection and macrophage cholesterol metabolism.
J. Leukoc. Biol.,
November 1, 2006;
80(5):
1044 - 1051.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Vaughan and J. F. Oram
ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL
J. Lipid Res.,
November 1, 2006;
47(11):
2433 - 2443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. G. Frank, M. W.-C. Cheung, S. Pavlides, G. Llaverias, D. S. Park, and M. P. Lisanti
Caveolin-1 and regulation of cellular cholesterol homeostasis
Am J Physiol Heart Circ Physiol,
August 1, 2006;
291(2):
H677 - H686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. M. Wang, H. P. Kim, R. Song, and A. M. K. Choi
Caveolin-1 Confers Antiinflammatory Effects in Murine Macrophages via the MKK3/p38 MAPK Pathway
Am. J. Respir. Cell Mol. Biol.,
April 1, 2006;
34(4):
434 - 442.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Gaus, M. Rodriguez, K. R. Ruberu, I. Gelissen, T. M. Sloane, L. Kritharides, and W. Jessup
Domain-specific lipid distribution in macrophage plasma membranes
J. Lipid Res.,
July 1, 2005;
46(7):
1526 - 1538.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. O. Lungu, Z.-G. Jin, H. Yamawaki, T. Tanimoto, C. Wong, and B. C. Berk
Cyclosporin A Inhibits Flow-mediated Activation of Endothelial Nitric-oxide Synthase by Altering Cholesterol Content in Caveolae
J. Biol. Chem.,
November 19, 2004;
279(47):
48794 - 48800.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Llaverias, M. Vazquez-Carrera, R. M. Sanchez, V. Noe, C. J. Ciudad, J. C. Laguna, and M. Alegret
Rosiglitazone upregulates caveolin-1 expression in THP-1 cells through a PPAR-dependent mechanism
J. Lipid Res.,
November 1, 2004;
45(11):
2015 - 2024.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Mason, M. F. Walter, and R. F. Jacob
Effects of HMG-CoA Reductase Inhibitors on Endothelial Function: Role of Microdomains and Oxidative Stress
Circulation,
June 1, 2004;
109(21_suppl_1):
II-34 - II-41.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Fu, A. Hoang, G. Escher, R. G. Parton, Z. Krozowski, and D. Sviridov
Expression of Caveolin-1 Enhances Cholesterol Efflux in Hepatic Cells
J. Biol. Chem.,
April 2, 2004;
279(14):
14140 - 14146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. C. Sessa
Atheroprotection in the Absence of "Caves": Is it the Fat, the Vessels, or Both?
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2004;
24(1):
4 - 6.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Liu, A. E. Bortnick, M. Nickel, P. Dhanasekaran, P. V. Subbaiah, S. Lund-Katz, G. H. Rothblat, and M. C. Phillips
Effects of Apolipoprotein A-I on ATP-binding Cassette Transporter A1-mediated Efflux of Macrophage Phospholipid and Cholesterol: FORMATION OF NASCENT HIGH DENSITY LIPOPROTEIN PARTICLES
J. Biol. Chem.,
October 31, 2003;
278(44):
42976 - 42984.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Gargalovic and L. Dory
Cellular apoptosis is associated with increased caveolin-1 expression in macrophages
J. Lipid Res.,
September 1, 2003;
44(9):
1622 - 1632.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|